Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

G&L Clinical ResearchG&L Clinical Research
VS
iQoriQor
G&L Clinical Research

G&L Clinical Research

The Old Station House, Millburn, 07041, US

Last Update: 01/04/2026

View Profile
751/1000Fair

G&L Scientific provides expert consulting, staffing & support throughout the world & across multiple Therapeutic Areas—Oncology, Neurology & CNS, Cardiovascular, Pain, Respiratory, Dermatologics, GI, CNS, Vaccines, Immunology, Infectious Diseases.

NAICS:541615
NAICS Definition:Others
Employees:None
Subsidiaries:3
12-month incidents
0
Known data breaches
0
Attack type number
0
iQor

iQor

6700 N. Andrews Ave., Ste. 600 , Fort Lauderdale, FL, US, 33309

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.iqor.com
779/1000Fair

iQor CXBPO™ is a trusted partner in intelligent customer experience solutions for global brands and a portfolio company of Mill Point Capital. With 47,000+ employees across 11 countries, iQor combines three decades of expertise with AI-driven innovation to optimize perf...

NAICS:541615
NAICS Definition:Others
Employees:24,769
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
G&L Clinical Research

G&L Clinical Research

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
iQor

iQor

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Outsourcing and Offshoring Consulting Industry Avg (This Year)

No incidents recorded for G&L Clinical Research in 2026.

Incidents

Incidents vs Outsourcing and Offshoring Consulting Industry Avg (This Year)

No incidents recorded for iQor in 2026.

Incidents

Incident History - G&L Clinical Research (X = Date, Y = Severity)

G&L Clinical Research cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - iQor (X = Date, Y = Severity)

iQor cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
G&L Clinical Research

G&L Clinical Research

Incidents
No explicit notable incidents reported.
iQor

iQor

Incidents
No explicit notable incidents reported.

FAQ

Between G&L Clinical Research company and iQor company, which one has the best AI Cybersecurity Score ?
Between G&L Clinical Research company and iQor company, which one has experienced more cyber incidents in the past ?
Between G&L Clinical Research company and iQor company, which one has experienced more cyber incidents this year ?
Between G&L Clinical Research company and iQor company, which one has experienced at least one ransomware attack ?
Between G&L Clinical Research company and iQor company, which one has experienced at least one data breach ?
Between G&L Clinical Research company and iQor company, which one has experienced at least one targeted cyberattack ?
Between G&L Clinical Research company and iQor company, which one has experienced at least one vulnerability ?
Between G&L Clinical Research company and iQor company, which one holds the most compliance certifications ?
Between G&L Clinical Research company and iQor company, which one holds the fewest compliance certifications ?
Between G&L Clinical Research company and iQor company, which one has the most subsidiaries ?
Between G&L Clinical Research company and iQor company, which one has the largest number of employees ?
Between G&L Clinical Research and iQor, which company holds both SOC 2 Type 1 certifications ?
Between G&L Clinical Research and iQor, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - G&L Clinical Research or iQor ?
Which company is PCI DSS compliant - G&L Clinical Research or iQor ?
Between G&L Clinical Research and iQor, which company complies with HIPAA regulations for healthcare data ?
Between G&L Clinical Research and iQor, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-63261
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63260
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63259
SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63145
SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63144
SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8